MLchartDataset catalogue

Venclexta

Term · Oncology and biomedicine · MLC-T-ONC-009209

A drug used alone or with other drugs to treat certain adults with acute myeloid leukemia that is newly diagnosed and adults with chronic lymphocytic leukemia or small lymphocytic lymphoma. It is also being studied in the treatment of other types of cancer. Venclexta binds to a protein called BCL2, which is found on some types of cancer cells. Blocking this protein may help kill cancer cells and may make them more sensitive to anticancer drugs. Venclexta is a type of BCL2 inhibitor. Also called venetoclax.

Table 1. Record
IdentifierMLC-T-ONC-009209
FieldOncology and biomedicine
Synonymsvenetoclax
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009209",
  "term": "Venclexta",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with other drugs to treat certain adults with acute myeloid leukemia that is newly diagnosed and adults with chronic lymphocytic leukemia or small lymphocytic lymphoma. It is also being studied in the treatment of other types of cancer. Venclexta binds to a protein called BCL2, which is found on some types of cancer cells. Blocking this protein may help kill cancer cells and may make them more sensitive to anticancer drugs. Venclexta is a type of BCL2 inhibitor. Also called venetoclax.",
  "synonyms": [
    "venetoclax"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/venclexta/"
}

Record 17,184 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.